The Impact of the Delay on the New Jersey Economy
The New Jersey Cannabis Regulatory Commission has delayed the adult-use market again, citing a lack of supply from current medical operators as one reason for the postponement.
According to one multi-state operator, that shouldn’t be the case. In an exclusive statement provided by the NJ CRC, the commission says it wants to make sure the MSO’s operating in the state have the ability to provide to both the current medical patients they assist, as well as the incoming adult-use market.
What is the New Jersey Cannabis Regulatory Commission
The New Jersey Cannabis Regulatory Commission (NJ CRC) is a five-member state commission that was created in 2019 to oversee the regulation of the cannabis industry in New Jersey. The NJ CRC is responsible for issuing licenses for cultivators, manufacturers, and retailers, as well as setting regulations for the industry. The commission is also tasked with ensuring that the cannabis industry operates in a safe and fair manner.
The NJ CRC held its first public meeting on March 24, 2022, where it unanimously approved 68 conditional license applications for recreational cannabis cultivators and manufacturers. This was a major step forward in opening up the recreational cannabis market in New Jersey. However, the industry has been delayed due to several factors, including the coronavirus pandemic and disagreements among state lawmakers.
Despite these delays, the NJ CRC is committed to ensuring that the cannabis industry in New Jersey operates in a safe and fair manner. We can expect great things from the commission in the future as they continue to work towards their goal of creating a well-regulated cannabis industry in New Jersey.
The New Jersey Cannabis Regulatory Commission has delayed the adult-use market again, citing a lack of supply from current medical operators as one reason for the postponement.
This latest delay means that the much-anticipated launch of the adult-use market in New Jersey will now be pushed back to early 2022.
The New Jersey Cannabis Regulatory Commission is dedicated to ensuring that all cannabis items are safe for human consumption. As a result, we feel it is only reasonable to give the present medical operators the first opportunity to join the adult-use market.
The commission is hopeful that this delay will be a short one, and that the adult-use market will be able to launch in early 2022. In the meantime, we urge all parties involved to continue working together to ensure a smooth transition for all patients and customers.
The NJ CRC is committed to ensuring physical integrity and product safety for all cannabis products entering the New Jersey market. They are also working diligently with stakeholders to ensure a smooth transition to adult-use legalization.
Extracted from the Live Show of Cannabis Legalization News: https://youtu.be/uvaF2nk7uh0
Register for the webinar here: https://bit.ly/3ufDqYc
#cannabis #newjersey
Please be 21+ because this is about the legal & legitimately lawful (at the state level) cannabis industry.
? We can help with your cannabis business. Get in touch here! (https://bit.ly/3jHLITp)
? Mastermind 10% Discount Code: AppDoneRight (https://bit.ly/3LXJf4S)
? Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr)
? Become a member for exclusive perks! (https://bit.ly/2UavaLj)
Cannabis News of The Week | Cannabis Legalization News
marijuana legalization, marijuana legalization federal, marijuana legalization 2022, marijuana legalization news us, marijuana legalization,
cannabis legalization news
cannabis news
cannabis international news
cannabis news federal
marijuana legalization news
marijuana legalization 2022
marijuana news
marijuana business
cannabis business
cannabis industry news
420 news
weed legalization news
cannabis business news
